Insider · CIK 0001191251

Sandman Paul W

Reports to the SEC for 2 companies · INCLINE VILLAGE, NV

sec.gov

Transactions

Companies

Filings

CIK

0001191251

Forms 4 and 5

Insider transactions

49 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-06-20	PDL BIOPHARMA, INC.Stock Option (right to buy)A Award	Director	AAward	+126K sh	$3.00	+$378K	126,050
2018-06-08	PDL BIOPHARMA, INC.A Award	Director	AAward	+54.3K sh	$2.76	+$150K	262,800
2017-06-09	PDL BIOPHARMA, INC.A Award	Director	AAward	+60.7K sh	$2.47	+$150K	208,452
2016-06-02	PDL BIOPHARMA, INC.A Award	Director	AAward	+71K sh	$3.52	+$250K	147,723
2015-05-28	PDL BIOPHARMA, INC.A Award	Director	AAward	+22.1K sh	$6.80	+$150K	76,700
2013-05-21	PDL BIOPHARMA, INC.A Award	Director	AAward	+5,974 sh	$8.37	+$50K	49,270
2012-06-05	PDL BIOPHARMA, INC.A Award	Director	AAward	+7,924 sh	$6.31	+$50K	43,296
2011-06-22	PDL BIOPHARMA, INC.A Award	Director	AAward	+8,489 sh	$5.89	+$50K	35,372
2010-06-09	PDL BIOPHARMA, INC.A Award	Director	AAward	+9,900 sh	$5.05	+$50K	26,883
2009-06-04	PDL BIOPHARMA, INC.A Award	Director	AAward	+6,983 sh	$7.16	+$50K	16,983
2009-04-08	PDL BIOPHARMA, INC.P Purchase	Director	PPurchase	+10K sh	$7.38	+$73.8K	52,500
2009-04-08	PDL BIOPHARMA, INC.P Purchase	Director	PPurchase	+10K sh	$7.38	+$73.8K	10,000
2007-07-01	BSXBOSTON SCIENTIFIC CORPM Exercise/Conversion	EVP and General Counsel	MExercise/Conversion	+8,000 sh	—	—	41,866
2007-07-01	BSXBOSTON SCIENTIFIC CORPF Tax Payment	EVP and General Counsel	FTax Payment	−3,340 sh	$15.48	−$51.7K	38,526
2007-07-01	BSXBOSTON SCIENTIFIC CORP · Deferred Stock UnitsM Exercise/Conversion	EVP and General Counsel	MExercise/Conversion	−8,000 sh	—	—	40,700
2005-07-01	BSXBOSTON SCIENTIFIC CORP · Deferred Stock UnitsA Award	EVP and General Counsel	AAward	+40K sh	—	—	40,000
2005-07-01	BSXBOSTON SCIENTIFIC CORP · Stock Option (right to buy)A Award	EVP and General Counsel	AAward	+100K sh	—	—	100,000
2005-01-03	BSXBOSTON SCIENTIFIC CORP · Stock Option (Right to Buy)A Award	EVP and General Counsel	AAward	+60K sh	—	—	60,000
2003-11-26	BSXBOSTON SCIENTIFIC CORPM Exercise/Conversion	EVP and General Counsel	MExercise/Conversion	+220K sh	$6.94	+$1.53M	252,288
2003-11-26	BSXBOSTON SCIENTIFIC CORPS Sale	EVP and General Counsel	SSale	−7,000 sh	$34.81	−$244K	245,288
2003-11-26	BSXBOSTON SCIENTIFIC CORPS Sale	EVP and General Counsel	SSale	−1,400 sh	$34.82	−$48.7K	243,888
2003-11-26	BSXBOSTON SCIENTIFIC CORPS Sale	EVP and General Counsel	SSale	−1,500 sh	$34.83	−$52.2K	242,388
2003-11-26	BSXBOSTON SCIENTIFIC CORPS Sale	EVP and General Counsel	SSale	−12.7K sh	$34.85	−$443K	229,688
2003-11-26	BSXBOSTON SCIENTIFIC CORPS Sale	EVP and General Counsel	SSale	−100 sh	$34.86	−$3,486	229,588
2003-11-26	BSXBOSTON SCIENTIFIC CORPS Sale	EVP and General Counsel	SSale	−4,900 sh	$34.87	−$171K	224,688
2003-11-26	BSXBOSTON SCIENTIFIC CORPS Sale	EVP and General Counsel	SSale	−28.5K sh	$34.88	−$994K	196,188
2003-11-26	BSXBOSTON SCIENTIFIC CORPS Sale	EVP and General Counsel	SSale	−3,300 sh	$34.89	−$115K	192,888
2003-11-26	BSXBOSTON SCIENTIFIC CORPS Sale	EVP and General Counsel	SSale	−12.4K sh	$34.90	−$433K	180,488
2003-11-26	BSXBOSTON SCIENTIFIC CORPS Sale	EVP and General Counsel	SSale	−3,100 sh	$34.91	−$108K	177,388
2003-11-26	BSXBOSTON SCIENTIFIC CORPS Sale	EVP and General Counsel	SSale	−1,600 sh	$34.92	−$55.9K	175,788
2003-11-26	BSXBOSTON SCIENTIFIC CORPS Sale	EVP and General Counsel	SSale	−8,400 sh	$34.93	−$293K	167,388
2003-11-26	BSXBOSTON SCIENTIFIC CORPS Sale	EVP and General Counsel	SSale	−3,700 sh	$34.94	−$129K	163,688
2003-11-26	BSXBOSTON SCIENTIFIC CORPS Sale	EVP and General Counsel	SSale	−700 sh	$34.95	−$24.5K	162,988
2003-11-26	BSXBOSTON SCIENTIFIC CORPS Sale	EVP and General Counsel	SSale	−500 sh	$34.96	−$17.5K	162,488
2003-11-26	BSXBOSTON SCIENTIFIC CORPS Sale	EVP and General Counsel	SSale	−4,600 sh	$34.97	−$161K	157,888
2003-11-26	BSXBOSTON SCIENTIFIC CORPS Sale	EVP and General Counsel	SSale	−300 sh	$34.98	−$10.5K	157,588
2003-11-26	BSXBOSTON SCIENTIFIC CORPS Sale	EVP and General Counsel	SSale	−74.3K sh	$35.00	−$2.6M	83,288
2003-11-26	BSXBOSTON SCIENTIFIC CORPS Sale	EVP and General Counsel	SSale	−9,400 sh	$35.02	−$329K	73,888
2003-11-26	BSXBOSTON SCIENTIFIC CORPS Sale	EVP and General Counsel	SSale	−20K sh	$35.03	−$701K	53,888
2003-11-26	BSXBOSTON SCIENTIFIC CORPS Sale	EVP and General Counsel	SSale	−2,000 sh	$35.04	−$70.1K	51,888
2003-11-26	BSXBOSTON SCIENTIFIC CORPS Sale	EVP and General Counsel	SSale	−4,000 sh	$35.05	−$140K	47,888
2003-11-26	BSXBOSTON SCIENTIFIC CORPS Sale	EVP and General Counsel	SSale	−3,600 sh	$35.09	−$126K	44,288
2003-11-26	BSXBOSTON SCIENTIFIC CORPS Sale	EVP and General Counsel	SSale	−1,400 sh	$35.10	−$49.1K	42,888
2003-11-26	BSXBOSTON SCIENTIFIC CORPS Sale	EVP and General Counsel	SSale	−5,100 sh	$35.11	−$179K	37,788
2003-11-26	BSXBOSTON SCIENTIFIC CORPS Sale	EVP and General Counsel	SSale	−300 sh	$35.12	−$10.5K	37,488
2003-11-26	BSXBOSTON SCIENTIFIC CORPS Sale	EVP and General Counsel	SSale	−3,100 sh	$35.13	−$109K	34,388
2003-11-26	BSXBOSTON SCIENTIFIC CORPS Sale	EVP and General Counsel	SSale	−2,100 sh	$35.15	−$73.8K	32,288
2003-11-26	BSXBOSTON SCIENTIFIC CORP · Stock Option (Right to Buy)M Exercise/Conversion	EVP and General Counsel	MExercise/Conversion	−220K sh	—	—	0
2003-01-03	BSXBOSTON SCIENTIFIC CORPD Disposition to Issuer	EVP and General Counsel	DDisposition to Issuer	—	$15565.00	—	1

Recent filings

Accepted (ET)
Jun 244
Sandman Paul W0000882104-19-000069
SEC(opens sec.gov)
Jun 124
Sandman Paul W0000882104-18-000062
SEC(opens sec.gov)
Jun 124
PDL BIOPHARMA, INC.0000882104-17-000067
SEC(opens sec.gov)
Jun 34
PDL BIOPHARMA, INC.0000882104-16-000151
SEC(opens sec.gov)
May 294
PDL BIOPHARMA, INC.0000882104-15-000035
SEC(opens sec.gov)
May 214
Sandman Paul W0000882104-13-000015
SEC(opens sec.gov)
Jun 64
Sandman Paul W0000882104-12-000009
SEC(opens sec.gov)
Jul 64
Sandman Paul W0001209191-11-038544
SEC(opens sec.gov)
Jun 104
Sandman Paul W0001209191-10-033581
SEC(opens sec.gov)
Jun 84
SANDMAN PAUL W0001209191-09-031242
SEC(opens sec.gov)
Apr 134/A
SANDMAN PAUL W0001181431-09-019862
SEC(opens sec.gov)
Apr 94
SANDMAN PAUL W0001181431-09-019625
SEC(opens sec.gov)
Jul 54
BOSTON SCIENTIFIC CORP0001225208-07-006541
SEC(opens sec.gov)
Jul 64
BOSTON SCIENTIFIC CORP0000885725-05-000236
SEC(opens sec.gov)
Jan 54
SANDMAN PAUL W0000885725-05-000049
SEC(opens sec.gov)
Dec 14
SANDMAN PAUL W0000885725-03-000138
SEC(opens sec.gov)

Companies

Address

C/O PDL BIOPHARMA, INC. 932 SOUTHWOOD BLVD

INCLINE VILLAGE, NV, 89451